L3Harris Technologies에 대한 매도 수량은 투자자에게 L3Harris Technologies의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

L3Harris Technologies (NYSE:LHX) 주식, 공매도 수량 보고

L3Harris Technologies

L3Harris Technologies provides products for the command, control, communications, computers, intelligence, surveillance, and reconnaissance, or C4ISR, market. The firm produces uncrewed aerial vehicles, sensors, and avionics, provides military and commercial training services, and maintains the US Federal Aviation Administration's communications infrastructure. In July 2023, the company acquired Aerojet Rocketdyne, a key supplier of rocket motors to the space and defense industry.

Earnings

News

Price Target

Markets

Analyst Ratings

Trading Ideas

PLTR

팔란티어 테크놀로지스(NYSE:PLTR)는 11월 4일 월요일 시장 종료 후 3분기 실적을 발표할 예정이다. 애널리스트들은 덴버, 콜로라도에 본사를 둔 이 회사가 분기당 9센트의 주당 순이익을 보고할 것으로 예상하고 있으며, 이는 지난해 같은 기간의 7센트에서 증가한 수치이다. 팔란티어 테크놀로지스는 이번 분기에 7억 1,130만 달러의 매출을 보고할 것으로 예상하고 있다.

팔란티어 3분기 실적 준비 중: 월가 최고의 분석가들의 최근 예측 변경 사항은?

Equities

ETFs

ACHR

ARKK

ARKQ

ARKW

ARKX

TSLA

수요일에 캐시 우드가 이끄는 아크 인베스트가 몇 가지 중요한 거래를 했다. 가장 주목할 만한 거래는 테슬라(NASDAQ:TSLA), 어드밴스드 마이크로 디바이시스(NASDAQ:AMD), 팔란티어 테크놀로지스(NYSE:PLTR)와 관련된 것이다.

캐시 우드의 기술주 덱 섞기: 테슬라와 팔란티어를 계속 처분, AMD와 메타 주식 매입

피터 틸(Peter Thiel)이 공동 설립한 비밀 데이터 분석 회사인 팔란티어 테크놀로지스(NYSE:PLTR)는 방산업체인 L3해리스 테크놀로지스(NYSE:LHX)와 전략적 파트너십을 체결했다. 이들 두 회사의 CEO는 이 협력이 미국 군사 기술을 발전시킬 잠재력을 강조했다.

팔란티어 CEO 알렉스 카프, L3해리스와의 파트너십에 대해 언급: &#39;더 나은 네트워크 구축&#39;

L3Harris Technologies Inc

Offerings

PLBY

Playboy Announced The Closing Of Its Sale Of 14.9M Newly Issued Shares In A Private Placement At A Price Of $1.50 Per Share For A Total Purchase Price Of $22.35M

WIIM

SMCI

Super Micro Computer shares are trading lower after the company lowered its financial outlook.

Guidance

MCHP

Microchip Sees Q3 2024 Adj. EPS $0.29-$0.32

Helios Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLIO#NYSE">HLIO</a>) lowers FY2024 Adj EPS guidance from $2.25-2.45 to $2.10-2.20 vs $2.26 analyst estimate. Lowers FY2024 sales outlook from $825.00 million-840.00 million to $800.00 million-805.00 million vs $824.37 million estimate.

HLIO

Helios Technologies Lowers FY2024 Adj EPS Guidance from $2.25-2.45 to $2.10-2.20 vs $2.26 Est; Lowers FY2024 Sales Guidance from $825.00M-840.00M to $800.00M-805.00M vs $824.37M Est

MRC Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRC#NYSE">MRC</a>) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.20 by 10 percent. The company reported quarterly sales of $797.000 million which beat the analyst consensus estimate of $794.160 million by 0.36 percent. This is a 10.25 percent decrease over sales of $888.000 million the same period last year.

Earnings Beats

MRC Global Q3 2024 Adj. EPS $0.22 Beats $0.20 Estimate, Sales $797.000M Beat $794.160M Estimate

Helios Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLIO#NYSE">HLIO</a>) lowers FY2024 GAAP EPS guidance from $1.35-1.55 to $1.15-1.25 vs $1.41 analyst estimate..

Helios Technologies Lowers FY2024 GAAP EPS Guidance from $1.35-1.55 to $1.15-1.25 vs $1.41 Est

Supermicro Sees Q2 FY2025 Net Sales $5.5B-$6.1B, GAAP EPS $0.48-$0.58, Non-GAAP EPS $0.56-$0.65

Latham Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWIM#NASDAQ">SWIM</a>) reported quarterly earnings of $0.05 per share which missed the analyst consensus estimate of $0.06 by 16.67 percent. This is unchanged from the same period last year. The company reported quarterly sales of $150.50 million which missed the analyst consensus estimate of $152.30 million by 1.18 percent. This is a 6.40 percent decrease over sales of $160.78 million the same period last year.

Earnings Misses

SWIM

Latham Group Q3 EPS $0.05 Misses $0.06 Estimate, Sales $150.50M Miss $152.30M Estimate

QLYS

Qualys Raises 2024 Adj EPS Guidance From $5.46- $5.62 To $5.81 - $5.91 (Est $5.57), Lifts Revenue Guidance From $597.5M - $601.5M To $602.9M - $605.9M (Est $599.362M)

InnovAge Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INNV#NASDAQ">INNV</a>) affirms FY2025 sales outlook from $815.00 million-865.00 million to $815.00 million-865.00 million.

INNV

InnovAge Holding Affirms FY2025 Sales Guidance to $815.00M-865.00M  VS Est. 844.27M

Microchip Sees Q3 2024 Net Sales $1.025B-$1.095B

Super Micro Computer Expects To Report Prelim. Q1 Net Sales $5.9B-$6B (Prior $6B-$7B) , Non-GAAP EPS $0.75-$0.76 (Prior $0.67-$0.83)

trivago (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRVG#NASDAQ">TRVG</a>) reported quarterly losses of $(0.04) per share which missed the analyst consensus estimate of $0.02 by 300 percent. The company reported quarterly sales of $160.565 million which beat the analyst consensus estimate of $154.280 million by 4.07 percent. This is a 6.55 percent decrease over sales of $171.825 million the same period last year.

TRVG

trivago Q3 2024 GAAP EPS $(0.04) Misses $0.02 Estimate, Sales $160.565M Beat $154.280M Estimate

2024 Outlook
The company now expects:
<ul>
<li>Adjusted EBITDA, excluding reportable catastrophes6, to increase low double-digits, led by strong growth in Global Housing, with modest growth in Global Lifestyle.</li>
<li>Adjusted earnings, excluding reportable catastrophes, per diluted share6, to increase mid- to high-teens. Note: The metrics included within the company's outlook are non-GAAP financial measures and the company believes that it cannot, without unreasonable efforts, forecast certain information needed to reconcile to the GAAP measures, the probable significance of which cannot be determined. More information can be found in the Non-GAAP Financial Measures section.</li>
</ul>

Assurant Sees FY24 Adjusted EBITDA, Excluding Reportable Catastrophes, To Increase Low Double-Digits, Led By Strong Growth In Global Housing, With Modest Growth In Global Lifestyle; Adjusted Earnings, Excluding Reportable Catastrophes, Per Diluted Share, To Increase Mid- To High-Teens

InnovAge Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INNV#NASDAQ">INNV</a>) reported quarterly losses of $(0.04) per share which met the analyst consensus estimate. This is a 50 percent increase over losses of $(0.08) per share from the same period last year. The company reported quarterly sales of $205.14 million which beat the analyst consensus estimate of $203.33 million by 0.89 percent. This is a 12.42 percent increase over sales of $182.49 million the same period last year.

InnovAge Holding Q1 EPS $(0.04), Inline, Sales $205.14M Beat $203.33M Estimate

Assurant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIZ#NYSE">AIZ</a>) reported quarterly earnings of $3.00 per share which beat the analyst consensus estimate of $2.52 by 19.05 percent. This is a 30.07 percent decrease over earnings of $4.29 per share from the same period last year. The company reported quarterly sales of $2.97 billion which beat the analyst consensus estimate of $2.94 billion by 0.94 percent. This is a 6.98 percent increase over sales of $2.77 billion the same period last year.

Assurant Q3 Adj $3.00 Beats $2.52 Estimate, Sales $2.97B Beat $2.94B Estimate

Microchip Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHP#NASDAQ">MCHP</a>) reported quarterly earnings of $0.46 per share which beat the analyst consensus estimate of $0.43 by 6.98 percent. The company reported quarterly sales of $1.164 billion which beat the analyst consensus estimate of $1.152 billion by 1.01 percent. This is a 48.36 percent decrease over sales of $2.254 billion the same period last year.

Microchip Technology Q2 2025 Adj. EPS $0.46 Beats $0.43 Estimate, Sales $1.164B Beat $1.152B Estimate

Infinera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INFN#NASDAQ">INFN</a>) reported quarterly sales of $354.40 million which missed the analyst consensus estimate of $402.87 million by 12.03 percent. This is a 9.68 percent decrease over sales of $392.37 million the same period last year.

INFN

Infinera Q3 Sales $354.40M Miss $402.87M Estimate

CTKB

Cytek Biosciences Sees FY24 Revenue $203M-$210M Vs $203.937M; Sees 5-9% Revenue Growth

US Physical Therapy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USPH#NYSE">USPH</a>) reported quarterly earnings of $0.69 per share which beat the analyst consensus estimate of $0.68 by 1.47 percent. This is a 11.29 percent increase over earnings of $0.62 per share from the same period last year. The company reported quarterly sales of $168.033 million which beat the analyst consensus estimate of $164.381 million by 2.22 percent. This is a 12.02 percent increase over sales of $150.007 million the same period last year.

USPH

US Physical Therapy Q3 2024 Adj. EPS $0.69 Beats $0.68 Estimate, Sales $168.033M Beat $164.381M Estimate

Robert W. Baird analyst Peter Arment assigned a Buy rating on L3Harris Technologies (LHX – Research Report) on October 25 and set a price target of...

L3Harris Technologies: Strong Financial Performance and Promising Outlook Justify Buy Rating

L3Harris Technologies (LHX – Research Report), the Industrials sector company, was revisited by a Wall Street analyst yesterday. Analyst Sheila Kah...

L3Harris Technologies: Strong Organic Growth and Margin Expansion Drive Buy Rating

US Aerospace & Defense Analyst Kahyaoglu and Euro Aerospace & Defense Analyst Lemarie discuss 3Q reported earnings (relevant companies BA, HXL, RTX...

Jefferies aerospace & defense analysts hold analyst/industry conference call

As previously reported, BofA upgraded L3Harris Technologies (LHX) to Buy from Neutral with a price target of $300, up from $240. The firm had previ...

BofA upgrades 'leaner, focused' L3Harris Technologies to Buy

BofA upgraded L3Harris Technologies (LHX) to Buy from Neutral with a $300 price target Published first on TheFly – the ultimate source for real-tim...

L3Harris Technologies upgraded to Buy from Neutral at BofA

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need...

Wingstop upgraded, Estee Lauder downgraded: Wall Street's top analyst calls

Virtual Meeting to be held on November 5 at 2 pm hosted by Seaport Research. Published first on TheFly – the ultimate source for real-time, market-...

Comments

L3Harris Technologies

매도 수량

L3Harris Technologies (NYSE:LHX) 주식, 공매도 수량 보고

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌